Advertisement

Index by author

January 01, 1986; Volume 29,Issue 1

B

  1. Bali, J P

    1. Evidence for the existence of high affinity binding sites for indomethacin on human blood platelets.
      R Magous, J P Bali, R Escale, J P Girard, E Rechencq and J C Rossi
      Molecular Pharmacology January 1986, 29 (1) 39-44;

  2. Black, K A

    1. Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins.
      T R Tephly, K A Black, M D Green, B L Coffman, G A Dannan and F P Guengerich
      Molecular Pharmacology January 1986, 29 (1) 81-87;

  3. Bocckino, S B

    1. Regulation of protein synthesis in isolated hepatocytes by calcium-mobilizing hormones.
      C O Brostrom, S B Bocckino, M A Brostrom and E M Galuska
      Molecular Pharmacology January 1986, 29 (1) 104-111;

  4. Britt, M

    1. The interaction of the beta-anomer of doxorubicin with B and Z DNA.
      M Britt, F Zunino and J B Chaires
      Molecular Pharmacology January 1986, 29 (1) 74-80;

  5. Brostrom, C O

    1. Regulation of protein synthesis in isolated hepatocytes by calcium-mobilizing hormones.
      C O Brostrom, S B Bocckino, M A Brostrom and E M Galuska
      Molecular Pharmacology January 1986, 29 (1) 104-111;

  6. Brostrom, M A

    1. Regulation of protein synthesis in isolated hepatocytes by calcium-mobilizing hormones.
      C O Brostrom, S B Bocckino, M A Brostrom and E M Galuska
      Molecular Pharmacology January 1986, 29 (1) 104-111;

C

  1. Cascieri, M A

    1. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
      M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber
      Molecular Pharmacology January 1986, 29 (1) 34-38;

  2. Chaires, J B

    1. The interaction of the beta-anomer of doxorubicin with B and Z DNA.
      M Britt, F Zunino and J B Chaires
      Molecular Pharmacology January 1986, 29 (1) 74-80;

  3. Chicchi, G G

    1. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
      M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber
      Molecular Pharmacology January 1986, 29 (1) 34-38;

  4. Coffman, B L

    1. Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins.
      T R Tephly, K A Black, M D Green, B L Coffman, G A Dannan and F P Guengerich
      Molecular Pharmacology January 1986, 29 (1) 81-87;

  5. Colton, C D

    1. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
      M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber
      Molecular Pharmacology January 1986, 29 (1) 34-38;

  6. Couvineau, A

    1. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
      M Laburthe, A Couvineau and C Rouyer-Fessard
      Molecular Pharmacology January 1986, 29 (1) 23-27;

  7. Curtis, N R

    1. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
      M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber
      Molecular Pharmacology January 1986, 29 (1) 34-38;

D

  1. Dannan, G A

    1. Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins.
      T R Tephly, K A Black, M D Green, B L Coffman, G A Dannan and F P Guengerich
      Molecular Pharmacology January 1986, 29 (1) 81-87;

  2. Dempster, J

    1. The effects of chloramphenicol isomers on the motor end-plate nicotinic receptor-ion channel complex.
      F Henderson, C Prior, J Dempster and I G Marshall
      Molecular Pharmacology January 1986, 29 (1) 52-64;

E

  1. Escale, R

    1. Evidence for the existence of high affinity binding sites for indomethacin on human blood platelets.
      R Magous, J P Bali, R Escale, J P Girard, E Rechencq and J C Rossi
      Molecular Pharmacology January 1986, 29 (1) 39-44;

F

  1. Ferry, N

    1. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
      H J Motulsky, S J Shattil, N Ferry, D Rozansky and P A Insel
      Molecular Pharmacology January 1986, 29 (1) 1-6;

  2. Foxall, D

    1. Nuclear magnetic resonance studies of carbohydrate metabolism and substrate cycling in Fasciola hepatica.
      P M Matthews, D Foxall, L Shen and T E Mansour
      Molecular Pharmacology January 1986, 29 (1) 65-73;

  3. Freidinger, R M

    1. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
      M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber
      Molecular Pharmacology January 1986, 29 (1) 34-38;

G

  1. Galuska, E M

    1. Regulation of protein synthesis in isolated hepatocytes by calcium-mobilizing hormones.
      C O Brostrom, S B Bocckino, M A Brostrom and E M Galuska
      Molecular Pharmacology January 1986, 29 (1) 104-111;

  2. Girard, J P

    1. Evidence for the existence of high affinity binding sites for indomethacin on human blood platelets.
      R Magous, J P Bali, R Escale, J P Girard, E Rechencq and J C Rossi
      Molecular Pharmacology January 1986, 29 (1) 39-44;

  3. Green, M D

    1. Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins.
      T R Tephly, K A Black, M D Green, B L Coffman, G A Dannan and F P Guengerich
      Molecular Pharmacology January 1986, 29 (1) 81-87;

  4. Guengerich, F P

    1. Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins.
      T R Tephly, K A Black, M D Green, B L Coffman, G A Dannan and F P Guengerich
      Molecular Pharmacology January 1986, 29 (1) 81-87;

H

  1. Harris, C

    1. A new method to study glutathione adduct formation in periportal and pericentral regions of the liver lobule by micro-reflectance spectrophotometry.
      C Harris and R G Thurman
      Molecular Pharmacology January 1986, 29 (1) 88-96;

  2. Henderson, F

    1. The effects of chloramphenicol isomers on the motor end-plate nicotinic receptor-ion channel complex.
      F Henderson, C Prior, J Dempster and I G Marshall
      Molecular Pharmacology January 1986, 29 (1) 52-64;

I

  1. Insel, P A

    1. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. II. Relationship between receptor number and response.
      L C Mahan and P A Insel
      Molecular Pharmacology January 1986, 29 (1) 16-22;
    2. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
      H J Motulsky, S J Shattil, N Ferry, D Rozansky and P A Insel
      Molecular Pharmacology January 1986, 29 (1) 1-6;
    3. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle.
      L C Mahan and P A Insel
      Molecular Pharmacology January 1986, 29 (1) 7-15;

J

  1. Johnson, G V

    1. Quinacrine and 2-(4-phenylpiperidino)cyclohexanol (AH5183) inhibit acetylcholine release and synthesis in rat brain slices.
      R S Jope and G V Johnson
      Molecular Pharmacology January 1986, 29 (1) 45-51;

  2. Jope, R S

    1. Quinacrine and 2-(4-phenylpiperidino)cyclohexanol (AH5183) inhibit acetylcholine release and synthesis in rat brain slices.
      R S Jope and G V Johnson
      Molecular Pharmacology January 1986, 29 (1) 45-51;

L

  1. Laburthe, M

    1. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
      M Laburthe, A Couvineau and C Rouyer-Fessard
      Molecular Pharmacology January 1986, 29 (1) 23-27;

  2. Larsen, G L

    1. Cysteine conjugate beta-lyase in the gastrointestinal bacterium Eubacterium limosum.
      G L Larsen and J L Stevens
      Molecular Pharmacology January 1986, 29 (1) 97-103;

M

  1. Magous, R

    1. Evidence for the existence of high affinity binding sites for indomethacin on human blood platelets.
      R Magous, J P Bali, R Escale, J P Girard, E Rechencq and J C Rossi
      Molecular Pharmacology January 1986, 29 (1) 39-44;

  2. Maguire, J J

    1. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
      M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber
      Molecular Pharmacology January 1986, 29 (1) 34-38;

  3. Mahan, L C

    1. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. II. Relationship between receptor number and response.
      L C Mahan and P A Insel
      Molecular Pharmacology January 1986, 29 (1) 16-22;
    2. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle.
      L C Mahan and P A Insel
      Molecular Pharmacology January 1986, 29 (1) 7-15;

  4. Mansour, T E

    1. Nuclear magnetic resonance studies of carbohydrate metabolism and substrate cycling in Fasciola hepatica.
      P M Matthews, D Foxall, L Shen and T E Mansour
      Molecular Pharmacology January 1986, 29 (1) 65-73;

  5. Marshall, I G

    1. The effects of chloramphenicol isomers on the motor end-plate nicotinic receptor-ion channel complex.
      F Henderson, C Prior, J Dempster and I G Marshall
      Molecular Pharmacology January 1986, 29 (1) 52-64;

  6. Matthews, P M

    1. Nuclear magnetic resonance studies of carbohydrate metabolism and substrate cycling in Fasciola hepatica.
      P M Matthews, D Foxall, L Shen and T E Mansour
      Molecular Pharmacology January 1986, 29 (1) 65-73;

  7. Mazurek, A P

    1. Theoretical studies on the activation mechanism of the histamine H2-receptor: the proton transfer between histamine and a receptor model.
      H Weinstein, A P Mazurek, R Osman and S Topiol
      Molecular Pharmacology January 1986, 29 (1) 28-33;

  8. McKnight, A T

    1. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
      M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber
      Molecular Pharmacology January 1986, 29 (1) 34-38;

  9. Motulsky, H J

    1. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
      H J Motulsky, S J Shattil, N Ferry, D Rozansky and P A Insel
      Molecular Pharmacology January 1986, 29 (1) 1-6;

O

  1. Osman, R

    1. Theoretical studies on the activation mechanism of the histamine H2-receptor: the proton transfer between histamine and a receptor model.
      H Weinstein, A P Mazurek, R Osman and S Topiol
      Molecular Pharmacology January 1986, 29 (1) 28-33;

P

  1. Perlow, D S

    1. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
      M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber
      Molecular Pharmacology January 1986, 29 (1) 34-38;

  2. Prior, C

    1. The effects of chloramphenicol isomers on the motor end-plate nicotinic receptor-ion channel complex.
      F Henderson, C Prior, J Dempster and I G Marshall
      Molecular Pharmacology January 1986, 29 (1) 52-64;

R

  1. Rechencq, E

    1. Evidence for the existence of high affinity binding sites for indomethacin on human blood platelets.
      R Magous, J P Bali, R Escale, J P Girard, E Rechencq and J C Rossi
      Molecular Pharmacology January 1986, 29 (1) 39-44;

  2. Rossi, J C

    1. Evidence for the existence of high affinity binding sites for indomethacin on human blood platelets.
      R Magous, J P Bali, R Escale, J P Girard, E Rechencq and J C Rossi
      Molecular Pharmacology January 1986, 29 (1) 39-44;

  3. Rouyer-Fessard, C

    1. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
      M Laburthe, A Couvineau and C Rouyer-Fessard
      Molecular Pharmacology January 1986, 29 (1) 23-27;

  4. Rozansky, D

    1. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
      H J Motulsky, S J Shattil, N Ferry, D Rozansky and P A Insel
      Molecular Pharmacology January 1986, 29 (1) 1-6;

S

  1. Shattil, S J

    1. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
      H J Motulsky, S J Shattil, N Ferry, D Rozansky and P A Insel
      Molecular Pharmacology January 1986, 29 (1) 1-6;

  2. Shen, L

    1. Nuclear magnetic resonance studies of carbohydrate metabolism and substrate cycling in Fasciola hepatica.
      P M Matthews, D Foxall, L Shen and T E Mansour
      Molecular Pharmacology January 1986, 29 (1) 65-73;

  3. Stevens, J L

    1. Cysteine conjugate beta-lyase in the gastrointestinal bacterium Eubacterium limosum.
      G L Larsen and J L Stevens
      Molecular Pharmacology January 1986, 29 (1) 97-103;

T

  1. Tephly, T R

    1. Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins.
      T R Tephly, K A Black, M D Green, B L Coffman, G A Dannan and F P Guengerich
      Molecular Pharmacology January 1986, 29 (1) 81-87;

  2. Thurman, R G

    1. A new method to study glutathione adduct formation in periportal and pericentral regions of the liver lobule by micro-reflectance spectrophotometry.
      C Harris and R G Thurman
      Molecular Pharmacology January 1986, 29 (1) 88-96;

  3. Topiol, S

    1. Theoretical studies on the activation mechanism of the histamine H2-receptor: the proton transfer between histamine and a receptor model.
      H Weinstein, A P Mazurek, R Osman and S Topiol
      Molecular Pharmacology January 1986, 29 (1) 28-33;

V

  1. Veber, D F

    1. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
      M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber
      Molecular Pharmacology January 1986, 29 (1) 34-38;

W

  1. Weinstein, H

    1. Theoretical studies on the activation mechanism of the histamine H2-receptor: the proton transfer between histamine and a receptor model.
      H Weinstein, A P Mazurek, R Osman and S Topiol
      Molecular Pharmacology January 1986, 29 (1) 28-33;

  2. Williams, B

    1. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
      M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber
      Molecular Pharmacology January 1986, 29 (1) 34-38;

Z

  1. Zunino, F

    1. The interaction of the beta-anomer of doxorubicin with B and Z DNA.
      M Britt, F Zunino and J B Chaires
      Molecular Pharmacology January 1986, 29 (1) 74-80;
Back to top

In this issue

Advertisement